NEW ORLEANS, Sept. 12, 2017 -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until October 16, 2017 to file lead plaintiff applications in a securities class action lawsuit against Blue Apron Holdings, Inc. (NYSE:APRN), if they purchased the Company’s securities pursuant to its June 29, 2017 initial public offering (“IPO”) and/or on the open market between June 29, 2017 and August 9, 2017. This action is pending in the United States District Court for the Eastern District of New York.
Get Help
Blue Apron investors should visit us at https://www.claimsfiler.com/cases/nyse-aprn or call to speak to our claim center toll-free at (844) 367-9658.
About the Lawsuit
Blue Apron and certain of its executives are charged with failing to disclose material information in its Registration Statement filed in connection with its IPO, violating federal securities laws.
The alleged false and misleading statements and omissions include, but are not limited to, that: (i) advertising spending was significantly reduced, despite prior statements to the contrary; (ii) delivery delays or defects were causing customer retention problems; (iii) the Company’s new facility launch was delayed; (iv) new product offerings were delayed; and (v) as a result of the foregoing, Blue Apron’s Registration Statement was materially false and misleading at all relevant times.
About ClaimsFiler
ClaimsFiler has a single mission: to serve as the information source to help retail investors recover their share of billions of dollars from securities class action settlements. ClaimsFiler's team of experts monitor the securities class action landscape and cull information from a variety of sources to ensure comprehensive coverage across a broad range of financial instruments.
To learn more about ClaimsFiler, visit www.claimsfiler.com.


Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Washington Post Publisher Will Lewis Steps Down After Layoffs
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



